Microfluidics Market by Material, Component, Application, End User - Global Forecast 2025-2030- Product Image

Sale

Microfluidics Market by Material, Component, Application, End User - Global Forecast 2025-2030

Report
182 Pages
October 2024
Region: Global
360iResearch™
ID: 4968817

UP TO €695EUR$697USD£573GBP OFF until Dec 31^st 2024

The Microfluidics Market grew from USD 25.53 billion in 2023 to USD 31.84 billion in 2024. It is expected to continue growing at a CAGR of 25.37%, reaching USD 124.31 billion by 2030.

Microfluidics, a rapidly evolving technology, involves the manipulation of small volumes of fluids through microchannels. Its scope extends across various domains such as pharmaceuticals, biotechnology, and diagnostics, providing revolutionary applications in drug delivery, genetic research, and point-of-care testing. The necessity for microfluidics arises from its ability to downscale experiments, thereby reducing costs, enhancing portability, and speeding up analysis times. Key applications include lab-on-a-chip devices, organ-on-a-chip techniques, and advanced drug testing methodologies that leverage its precision and efficiency. In terms of end-use, industries such as healthcare, pharmaceuticals, and environmental monitoring are increasingly capitalizing on microfluidic innovations.

Key growth drivers in the microfluidics market include the rising demand for point-of-care diagnostics, advancements in healthcare research, and the ongoing miniaturization in technology trends. Moreover, the increasing need for rapid testing amid global health scenarios presents significant opportunities. The continuous progression in 3D printing technology further enriches microfluidic applications, making them more accessible and customizable. Emerging opportunities lie in personalized medicine and the development of portable, user-friendly diagnostic devices. Companies should invest in robust R&D, partnerships with research institutes, and remain proactive in adopting cutting-edge technologies to harness these opportunities.

However, market growth is challenged by technical complexities, such as the high cost of development and issues pertaining to standardization and commercialization. Regulatory hurdles and the need for specialized equipment and expertise also pose significant barriers. Innovations potential within microfluidics includes the development of cost-effective materials, enhancement of multiplexing capabilities, and the integration of AI for data analysis. Targeting resource-constrained environments with low-cost diagnostics might unlock substantial market segments. Ultimately, the microfluidics market is competitive yet promising, with a dynamic nature that requires continual adaptation and forward-thinking strategies to successfully navigate its challenges and opportunities.

Understanding Market Dynamics in the Microfluidics Market

The Microfluidics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
- Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
- Potential Applications of Drug Delivery using Microfluidics
Market Restraints
- Complicated and Time-Consuming Regulatory Approval Process
Market Opportunities
- Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
- Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
Market Challenges
- Integration of Microfluidics with Existing Workflows

Exploring Porter’s Five Forces for the Microfluidics Market

Porter’s Five Forces framework further strengthens the insights of the Microfluidics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Microfluidics Market

External macro-environmental factors deeply influence the performance of the Microfluidics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Microfluidics Market

The Microfluidics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Microfluidics Market

The Microfluidics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ascent Bio-Nano Technologies, Inc., Camozzi Automation S.p.A., Dolomite Microfluidics, IMT Masks and Divisions AG, PerkinElmer Inc., Thermo Fisher Scientific, Inc., Mission Bio, Inc., Idex Corporation, NanoCellect Biomedical., Abaxis, Inc., Quidel Corporation, Koninklijke Philips N.V., Parker-Hannifin Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Agilent Technologies, Inc., Danaher Corporation, Biosurfit SA, SMC Corporation, Micropoint Bioscience, Inc., Fluigent S.A., Elvesys Group, Achira Labs Pvt. Ltd., Sphere Fluidics Limited, OPKO Health, Inc., Cellix Limited, AbCellera Biologics Inc., and Fluidigm Corporation by Standard BioTools Inc..

Market Segmentation & Coverage

This research report categorizes the Microfluidics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Material
- Glass-based
- Polymer-based
- Silicon-based
Component
- Micro Needle
- Micro Pump
- Microfluidic Chip
Application
- In-Vitro Diagnostics
  - Clinical Diagnostics
  - Point-Of-Care Testing
  - Veterinary Diagnostics
- Pharmaceutical & Life Science Research
  - Lab Analytics
    - Capillary Electrophoresis
    - Cell-based Assays
    - Genomic analysis
    - Proteomic Analysis
  - Microdispensing
  - Microreaction
- Therapeutics
  - Drug Delivery
  - Wearable Devices
End User
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
5.1.1.2. Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
5.1.1.3. Potential Applications of Drug Delivery using Microfluidics
5.1.2. Restraints
5.1.2.1. Complicated and Time-Consuming Regulatory Approval Process
5.1.3. Opportunities
5.1.3.1. Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
5.1.3.2. Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
5.1.4. Challenges
5.1.4.1. Integration of Microfluidics with Existing Workflows
5.2. Market Segmentation Analysis
5.2.1. Material: Increasing use of glass and silicon-based materials for microfluidic devices
5.2.2. Component: Adoption of microneedles and pumps for minimal risk of infection
5.2.3. Application: Significant application of microfluidic devices in IVD and therapeutics
5.2.4. End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization

6. Microfluidics Market, by Material

6.1. Introduction
6.2. Glass-based
6.3. Polymer-based
6.4. Silicon-based

7. Microfluidics Market, by Component

7.1. Introduction
7.2. Micro Needle
7.3. Micro Pump
7.4. Microfluidic Chip

8. Microfluidics Market, by Application

8.1. Introduction
8.2. In-Vitro Diagnostics
8.2.1. Clinical Diagnostics
8.2.2. Point-Of-Care Testing
8.2.3. Veterinary Diagnostics
8.3. Pharmaceutical & Life Science Research
8.3.1. Lab Analytics
8.3.1.1. Capillary Electrophoresis
8.3.1.2. Cell-based Assays
8.3.1.3. Genomic analysis
8.3.1.4. Proteomic Analysis
8.3.2. Microdispensing
8.3.3. Microreaction
8.4. Therapeutics
8.4.1. Drug Delivery
8.4.2. Wearable Devices

9. Microfluidics Market, by End User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals & Diagnostic Centers
9.4. Pharmaceutical & Biotechnology Companies

10. Americas Microfluidics Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Microfluidics Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Microfluidics Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform
13.3.2. Bio-Techne to acquire Swiss spatial biology firm Lunaphore
13.3.3. CellFE Announces Launch of Novel Microfluidic Cellular Engineering Platform at ASGCT 2023 Annual Meeting

List of Figures

FIGURE 1. MICROFLUIDICS MARKET RESEARCH PROCESS
FIGURE 2. MICROFLUIDICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
FIGURE 7. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. MICROFLUIDICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. MICROFLUIDICS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. MICROFLUIDICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. MICROFLUIDICS MARKET DYNAMICS
TABLE 7. GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MICROFLUIDICS MARKET SIZE, BY GLASS-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MICROFLUIDICS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MICROFLUIDICS MARKET SIZE, BY SILICON-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRO PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROFLUIDIC CHIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MICROFLUIDICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MICROFLUIDICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MICROFLUIDICS MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MICROFLUIDICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MICROFLUIDICS MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MICROFLUIDICS MARKET SIZE, BY GENOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MICROFLUIDICS MARKET SIZE, BY PROTEOMIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICRODISPENSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MICROFLUIDICS MARKET SIZE, BY MICROREACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MICROFLUIDICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MICROFLUIDICS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MICROFLUIDICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MICROFLUIDICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. CANADA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 65. CANADA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 66. CANADA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. CANADA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 68. CANADA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 69. CANADA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 70. CANADA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 71. CANADA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. MEXICO MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 73. MEXICO MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 74. MEXICO MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. MEXICO MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 77. MEXICO MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. CHINA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 107. CHINA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 108. CHINA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. CHINA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 110. CHINA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 111. CHINA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 112. CHINA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 113. CHINA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. INDIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 115. INDIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 116. INDIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. INDIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 118. INDIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 119. INDIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 120. INDIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 121. INDIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. JAPAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 131. JAPAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 132. JAPAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. JAPAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 134. JAPAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 135. JAPAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 136. JAPAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 137. JAPAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. TAIWAN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. THAILAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 179. THAILAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 180. THAILAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. THAILAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 182. THAILAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 183. THAILAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 184. THAILAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 185. THAILAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 203. DENMARK MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 204. DENMARK MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 205. DENMARK MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. DENMARK MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 207. DENMARK MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 208. DENMARK MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 209. DENMARK MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 210. DENMARK MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. EGYPT MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 212. EGYPT MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 213. EGYPT MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. EGYPT MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 215. EGYPT MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 216. EGYPT MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 217. EGYPT MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 218. EGYPT MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. FINLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 220. FINLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 221. FINLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. FINLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 223. FINLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 224. FINLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 225. FINLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 226. FINLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. FRANCE MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 228. FRANCE MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 229. FRANCE MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. FRANCE MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 231. FRANCE MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 232. FRANCE MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 233. FRANCE MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 234. FRANCE MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. GERMANY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 236. GERMANY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 237. GERMANY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. GERMANY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 239. GERMANY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 240. GERMANY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 241. GERMANY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 242. GERMANY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. ITALY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 252. ITALY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 253. ITALY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. ITALY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 255. ITALY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 256. ITALY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 257. ITALY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 258. ITALY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. NORWAY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 276. NORWAY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 277. NORWAY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. NORWAY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 279. NORWAY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 280. NORWAY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 281. NORWAY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 282. NORWAY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. POLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 284. POLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 285. POLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. POLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 287. POLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 288. POLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 289. POLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 290. POLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. QATAR MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 292. QATAR MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 293. QATAR MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. QATAR MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 295. QATAR MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 296. QATAR MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 297. QATAR MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 298. QATAR MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. SPAIN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 324. SPAIN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 325. SPAIN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. SPAIN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 327. SPAIN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 328. SPAIN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 329. SPAIN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 330. SPAIN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 332. SWEDEN MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 333. SWEDEN MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 338. SWEDEN MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 340. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 341. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 346. SWITZERLAND MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. TURKEY MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 348. TURKEY MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 349. TURKEY MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 350. TURKEY MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 351. TURKEY MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE 352. TURKEY MICROFLUIDICS MARKET SIZE, BY LAB ANALYTICS, 2018-2030 (USD MILLION)
TABLE 353. TURKEY MICROFLUIDICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 354. TURKEY MICROFLUIDICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY IN-VITRO DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES MICROFLUIDICS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE RESEARCH, 2018-2030 (USD MILLION)
TABLE

Companies Mentioned

The leading players in the Microfluidics market, which are profiled in this report, include:

Abbott Laboratories
Ascent Bio-Nano Technologies, Inc.
Camozzi Automation S.p.A.
Dolomite Microfluidics
IMT Masks and Divisions AG
PerkinElmer Inc.
Thermo Fisher Scientific, Inc.
Mission Bio, Inc.
Idex Corporation
NanoCellect Biomedical.
Abaxis, Inc.
Quidel Corporation
Koninklijke Philips N.V.
Parker-Hannifin Corporation
Illumina, Inc.
Bio-Rad Laboratories, Inc.
BioFluidica
Agilent Technologies, Inc.
Danaher Corporation
Biosurfit SA
SMC Corporation
Micropoint Bioscience, Inc.
Fluigent S.A.
Elvesys Group
Achira Labs Pvt. Ltd.
Sphere Fluidics Limited
OPKO Health, Inc.
Cellix Limited
AbCellera Biologics Inc.
Fluidigm Corporation by Standard BioTools Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	182
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 31.84 Billion
Forecasted Market Value ( USD ) by 2030	$ 124.31 Billion
Compound Annual Growth Rate	25.3%
Regions Covered	Global
No. of Companies Mentioned	31

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3535EUR$3,545USD£2,916GBP €3928EUR$3,939USD£3,239GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6255EUR$6,272USD£5,158GBP €6950EUR$6,969USD£5,731GBP

Understanding Market Dynamics in the Microfluidics Market

Exploring Porter’s Five Forces for the Microfluidics Market

Applying PESTLE Analysis to the Microfluidics Market

Analyzing Market Share in the Microfluidics Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Microfluidics Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Microfluidic Devices Market (By Device Type, Material, Application, Industry and Region), Key Company Profiles, Trends, SWOT Analysis, and Recent Developments - Forecast to 2030

Microfluidics - Global Strategic Business Report

Microfluidic Device Systems - Global Strategic Business Report

Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029

Microfluidics Market Overview, 2024-29